Dataset Information


Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts.

ABSTRACT: EBV-related nasopharyngeal carcinomas (NPCs) still raise serious therapeutic problems. The therapeutic potential of the histone-deacetylase (HDAC) inhibitor Abexinostat was investigated using 5 preclinical NPC models including 2 patient-derived xenografts (C15 and C17). The cytotoxicity of Abexinostat used either alone or in combination with cis-platin or irradiation was assessed in vitro by MTT and clonogenic assays using 2 EBV-negative (CNE1 and HONE1) and 3 EBV-positive NPC models (C15, C17 and C666-1). Subsequently, the 3 EBV-positive models were used under the form of xenografts to assess the impact of systemic treatments by Abexinostat or combinations of Abexinostat with cis-platin or irradiation. Several cell proteins known to be affected by HDAC inhibitors and the small viral non-coding RNA EBER1 were investigated in the treated tumors. Synergistic cytotoxic effects of Abexinostat combined with cis-platin or irradiation were demonstrated in vitro for each NPC model. When using xenografts, Abexinostat by itself (12.5 mg/kg, BID, 4 days a week for 3 weeks) had significant anti-tumor effects against C17. Cooperative effects with cis-platin (2 mg/kg, IP, at days 3, 10 and 17) and irradiation (1 Gy) were observed for the C15 and C17 xenografts. Simultaneously two types of biological alterations were induced in the tumor tissue, especially in the C17 model: a depletion of the DNA-repair protein RAD51 and a stronger in situ detection of the small viral RNA EBER1. Overall, these results support implementation of phase I/II clinical trials of Abexinostat for the treatment of NPC. A depletion of RAD51 is likely to contribute to the cooperation of Abexinostat with DNA damaging agents. Reduction of RAD51 combined to enhanced detection of EBER 1 might be helpful for early assessment of tumor response.

SUBMITTER: Gressette M 

PROVIDER: S-EPMC3949989 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2007-12-01 | E-TABM-382 | ArrayExpress
2017-01-01 | S-EPMC5593556 | BioStudies
2014-01-01 | S-EPMC4101232 | BioStudies
2007-01-01 | S-EPMC2042179 | BioStudies
2017-01-01 | S-EPMC5129462 | BioStudies
1000-01-01 | S-EPMC5362956 | BioStudies
2017-01-01 | S-EPMC5215905 | BioStudies
2019-01-01 | S-EPMC6930629 | BioStudies
1000-01-01 | S-EPMC6220246 | BioStudies
2015-01-01 | S-EPMC4645642 | BioStudies